BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19041765)

  • 1. Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis.
    Babaev VR; Chew JD; Ding L; Davis S; Breyer MD; Breyer RM; Oates JA; Fazio S; Linton MF
    Cell Metab; 2008 Dec; 8(6):492-501. PubMed ID: 19041765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation.
    Minami M; Shimizu K; Okamoto Y; Folco E; Ilasaca ML; Feinberg MW; Aikawa M; Libby P
    J Biol Chem; 2008 Apr; 283(15):9692-703. PubMed ID: 18270204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.
    Banu SK; Lee J; Speights VO; Starzinski-Powitz A; Arosh JA
    Mol Endocrinol; 2009 Aug; 23(8):1291-305. PubMed ID: 19407222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage IKKα Deficiency Suppresses Akt Phosphorylation, Reduces Cell Survival, and Decreases Early Atherosclerosis.
    Babaev VR; Ding L; Zhang Y; May JM; Lin PC; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):598-607. PubMed ID: 26848161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4.
    Chun KS; Akunda JK; Langenbach R
    Cancer Res; 2007 Mar; 67(5):2015-21. PubMed ID: 17332329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation.
    Hubbard NE; Lee S; Lim D; Erickson KL
    Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):287-94. PubMed ID: 11993722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice.
    Miyaura C; Inada M; Suzawa T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
    J Biol Chem; 2000 Jun; 275(26):19819-23. PubMed ID: 10749873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early pregnancy induced expression of prostaglandin E2 receptors EP2 and EP4 in the ovine endometrium and regulated by interferon tau through multiple cell signaling pathways.
    Lee J; Banu SK; Nithy TK; Stanley JA; Arosh JA
    Mol Cell Endocrinol; 2012 Jan; 348(1):211-23. PubMed ID: 21907262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.
    Li X; Pilbeam CC; Pan L; Breyer RM; Raisz LG
    Bone; 2002 Apr; 30(4):567-73. PubMed ID: 11934647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2/PGE4 receptors, protein kinase A, I kappa B kinase, and NF-kappa B.
    Chen BC; Liao CC; Hsu MJ; Liao YT; Lin CC; Sheu JR; Lin CH
    J Immunol; 2006 Jul; 177(1):681-93. PubMed ID: 16785567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice.
    Babaev VR; Hebron KE; Wiese CB; Toth CL; Ding L; Zhang Y; May JM; Fazio S; Vickers KC; Linton MF
    J Lipid Res; 2014 Nov; 55(11):2296-308. PubMed ID: 25240046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.
    Cipollone F; Fazia ML; Iezzi A; Cuccurullo C; De Cesare D; Ucchino S; Spigonardo F; Marchetti A; Buttitta F; Paloscia L; Mascellanti M; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1925-31. PubMed ID: 16020747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors.
    Kobayashi Y; Take I; Yamashita T; Mizoguchi T; Ninomiya T; Hattori T; Kurihara S; Ozawa H; Udagawa N; Takahashi N
    J Biol Chem; 2005 Jun; 280(25):24035-42. PubMed ID: 15834134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
    Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
    Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury.
    Strong VE; Winter J; Yan Z; Smyth GP; Mestre JR; Maddali S; Schaefer PA; Yurt RW; Stapleton PP; Daly JM
    Surgery; 2001 Aug; 130(2):249-55. PubMed ID: 11490357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms.
    Aoki T; Frȍsen J; Fukuda M; Bando K; Shioi G; Tsuji K; Ollikainen E; Nozaki K; Laakkonen J; Narumiya S
    Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor.
    Takayama K; García-Cardena G; Sukhova GK; Comander J; Gimbrone MA; Libby P
    J Biol Chem; 2002 Nov; 277(46):44147-54. PubMed ID: 12215436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines.
    Ono K; Akatsu T; Kugai N; Pilbeam CC; Raisz LG
    Bone; 2003 Nov; 33(5):798-804. PubMed ID: 14623055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.